All three Heart Group (now NEOCS) vascular labs are reaccredited and are among select vascular labs in the United States, Canada, and Puerto Rico to meet or exceed the ICAVL (Intersocietal Commission for the Accreditation of Vascular Laboratories) standards for noninvasive vascular testing. Every aspect of the labs daily operations and its impact on the quality of health care provided to patients is assessed and reviewed. Participation in the accreditation process demonstrates the lab's attention to a high level of patient care and quality testing.

Cardiovascular disease is the leading cause of death in the United States with one American dying every 32 seconds from disorders of the heart and blood vessels. There are 500,000 new strokes annually. Early detection of life-threatening vascular diseases is possible through the use of noninvasive vascular testing techniques performed within vascular labs.